Hepatocellular carcinoma occurs frequently and early after treatment in HCV genotype 3 infected persons treated with DAA regimens.

BMC Gastroenterol · 2020 · PMC7137260 · PMID 32252635

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In our analysis, HCV genotype 3 infected persons treated with a DAA-based regimen were at a higher numerical risk of incident HCC, though this association did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.